HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hasita Horlad Selected Research

PD 128042

6/2022Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hasita Horlad Research Topics

Disease

21Neoplasms (Cancer)
06/2022 - 01/2008
6Lymphoma (Lymphomas)
06/2022 - 01/2013
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2017 - 07/2013
3Neoplasm Metastasis (Metastasis)
11/2016 - 01/2011
3Hepatocellular Carcinoma (Hepatoma)
10/2010 - 01/2008
2Sarcoma (Soft Tissue Sarcoma)
01/2020 - 06/2013
2B-Cell Lymphoma (Lymphoma, B Cell)
07/2017 - 07/2017
2Atherosclerosis
07/2013 - 03/2012
2Hyperlipidemias (Hyperlipidemia)
07/2013 - 03/2012
1Arthritis (Polyarthritis)
01/2020
1Rheumatoid Arthritis
01/2020
1Inflammation (Inflammations)
01/2020
1Septic Shock (Toxic Shock Syndrome)
01/2020
1Disease Progression
03/2018
1Ductal Carcinoma
08/2017
1Breast Neoplasms (Breast Cancer)
08/2017
1Ovarian Neoplasms (Ovarian Cancer)
12/2016
1Renal Cell Carcinoma (Grawitz Tumor)
03/2016
1Stomach Neoplasms (Stomach Cancer)
07/2015
1Kidney Neoplasms (Kidney Cancer)
06/2015
1Fibrosis (Cirrhosis)
03/2014
1T-Cell Leukemia (Leukemia, T Cell)
01/2014
1Persistent Infection
01/2014
1Osteosarcoma (Osteogenic Sarcoma)
06/2013
1Glioma (Gliomas)
12/2012
1Cholangiocarcinoma
11/2012
1Hemorrhage
05/2012

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
07/2017 - 01/2011
4STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2017 - 01/2011
3onionin AIBA
06/2022 - 11/2016
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 07/2013
3CytokinesIBA
01/2020 - 01/2013
3Messenger RNA (mRNA)IBA
08/2017 - 06/2013
3MucinsIBA
07/2017 - 09/2015
3Immunoglobulins (Immunoglobulin)IBA
07/2017 - 09/2015
2CholesterolIBA
06/2022 - 03/2012
2Conditioned Culture MediaIBA
08/2017 - 01/2011
2ParaffinIBA
08/2017 - 11/2016
2Immune Checkpoint ProteinsIBA
07/2017 - 11/2016
2LigandsIBA
07/2017 - 11/2016
2Bromodeoxyuridine (BrdU)IBA
07/2013 - 12/2012
2Cholesterol Esters (Cholesteryl Esters)IBA
07/2013 - 03/2012
2Apolipoproteins E (ApoE)IBA
07/2013 - 03/2012
1LipidsIBA
06/2022
1Interleukin-10 (Interleukin 10)IBA
06/2022
1Sulfur Compounds (Compounds, Sulfur)IBA
06/2022
1PD 128042IBA
06/2022
1epimedokoreanin BIBA
01/2020
1epimedii flavoneIBA
01/2020
1CollagenIBA
01/2020
1FlavonoidsIBA
01/2020
1LipopolysaccharidesIBA
01/2020
1CD163 antigenIBA
03/2018
1TL 1IBA
07/2017
1Cell Adhesion Molecule-1IBA
07/2017
1Cell Adhesion MoleculesIBA
07/2017
1WP1066IBA
07/2017
1SulfurIBA
11/2016
1Cisplatin (Platino)FDA LinkGeneric
11/2016
1Interleukin-27 (Interleukin 27)IBA
11/2016
1HLA-DR Antigens (HLA-DR)IBA
03/2016
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2015
1MicroRNAs (MicroRNA)IBA
07/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2015
1MAP Kinase Kinase Kinase 5IBA
03/2014
1Scavenger Receptors (Scavenger Receptor)IBA
01/2014
1AlkaloidsIBA
07/2013
1Biological ProductsIBA
07/2013
1manzamine AIBA
07/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2013
1Antineoplastic Agents (Antineoplastics)IBA
06/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2013
1corosolic acidIBA
06/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2013
1Complement C5a (Complement 5a)IBA
01/2013
15- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA
12/2012
1Small Interfering RNA (siRNA)IBA
12/2012
1Macrophage Colony-Stimulating FactorIBA
12/2012
1A-factor (Streptomyces)IBA
11/2012
1isoesculeogenin AIBA
03/2012
1esculeoside AIBA
03/2012
1TransferasesIBA
03/2012
1Acyl Coenzyme A (Acyl CoA)IBA
03/2012
1tomatidineIBA
03/2012
1TomatineIBA
03/2012
1Mitogen-Activated Protein KinasesIBA
01/2011
1Tumor Biomarkers (Tumor Markers)IBA
10/2010

Therapy/Procedure

7Therapeutics
06/2022 - 01/2008
2Immunotherapy
07/2017 - 11/2016
2Drug Therapy (Chemotherapy)
08/2016 - 01/2011
1Oral Administration
01/2020
1Ligation
03/2014
1Length of Stay
05/2012
1Hepatectomy
10/2010
1Radiofrequency Ablation
05/2009